The bruton's tyrosine kinase inhibitor evobrutinib ameliorates meningeal inflammation in experimental autoimmune encephalomyelitis (EAE)

Authors
Category Primary study
JournalNeurology
Year 2020
This article has no abstract
Epistemonikos ID: 35a00a5b5393eb4ed850cc7f7369e0e3c2b450ed
First added on: Feb 12, 2025